A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation.

Youyong Yuan,Yilong Chen,Ben Zhong Tang,Bin Liu
DOI: https://doi.org/10.1039/c3cc49516g
IF: 4.9
2014-01-01
Chemical Communications
Abstract:A targeted theranostic platinum(IV) prodrug based on a luminogen with aggregation-induced emission (AIE) characteristics was developed for selective and real-time monitoring of drug activation in situ.
What problem does this paper attempt to address?